EN
FR
Home
About
About
Abionyx
Management
Board of Directors
Specialized Committees
- Audit Committee
- Remuneration Committee
Scientific Advisory Board
Our Assets
Our Assets
CER 001
CER 002
CER 209
Media
Media
Press releases
Investors
Investors
Regulated information
Shareholder meeting
Investor presentations
Corporate presentation
Abionyx on stock market
Investor Contacts
Financial Calendar
Media
Press releases
All Abionyx press releases
New Data for CER-001 presented in key Oral Session at AMERICAN HEART ASSOCIATION (AHA) CONFERENCE 2015
Fichier:
PR_Cerenis_Therapeutics_AHA_10112015_FINAL.pdf
